By
Rajiv Shah, president of The Rockefeller Foundation and former administrator of USAID, believes in leveraging the passion of individuals to affect large-scale change in society.
By
Takeda is a global biopharmaceutical corporation with an ambitious zero-waste-to-landfill goal. BioLife, a subsidiary of Takeda, sought to develop prioritized recycling strategies in support of Takeda’s sustainability pledge and goals. A team of three Sustainable Business Lab (S-Lab) students tackle...
By
Steve Rusckowski, SM ’84, former chairperson, CEO, and president of Quest Diagnostics, believes small changes can have a major impact on company culture.
An intensive food-as-medicine program showed no improvement in glycemic control in patients with type 2 diabetes and food insecurity: MIT Sloan.
"Randomized clinical trials are key tools for discerning what works best, for whom and why, information that we should all be hungry for."
Study of rigorous trial, co-authored by Erwin H. Schell Professor Joseph Doyle, shows mixed results and suggests need to keep examining how nutrition can combat a pervasive disease.
HSI co-presented a series of lunchtime seminars with Doug Williams of the Martin Trust Center during the Fall of 2023.
As an MIT Sloan grad turned dentist turned writer, Gloria Chao, SB ’08, prefers creating magic for her characters to cleaning people’s mouths.
By
For the 23 student-led teams in the MIT delta v 2023 cohort, Demo Day marked the end of their journey through the three-month educational accelerator and their first steps out into the world.
"To understand the job challenges nurses face, health care leaders need to listen to nurses' own words about burnout."
